Back to Search
Start Over
Dendritic cell-cediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
- Source :
- Scopus-Elsevier, Università degli Studi di Siena-IRIS
- Publication Year :
- 2005
-
Abstract
- Gemcitabine, oxaliplatin, leucovorin, and 5-fluorouracil (GOLF) is a novel multidrug regimen inducing high levels of necrosis and apoptosis in colon carcinoma cells. This regimen is also able to promote a process of Ag remodeling including up-regulation of immunotherapy targets like carcinoembryonic Ag (CEA), thymidylate synthase (TS). We have conducted a preclinical study aimed to investigate whether these drug-induced modifications would also enhance colon cancer cell immunogenicity. Several CTL lines were thus generated by in vitro stimulating human HLA-A(*)02.01+ PBMCs, from normal donors and colon cancer patients, with autologous dendritic cells cross-primed with cell lysates of colon cancer cells untreated, irradiated, or previously exposed to different drug treatments including the GOLF regimen. Class I HLA-restricted cytolytic activity of these CTL lines was tested against colon cancer cells and CEA and TS gene transfected target cells. These experiments revealed that CTLs sensitized with GOLF-treated cancer cells were much more effective than those sensitized with the untreated colon carcinoma cells or those exposed to the other treatments. CTL lines sensitized against the GOLF-treated colon cancer cells, also expressed a greater percentage of T-lymphocyte precursors able to recognize TS- and CEA-derived peptides. These results suggest that GOLF regimen is a powerful antitumor and immunomodulating regimen that can make the tumor cells a suitable means to induce an Ag-specific CTL response. These results suggest that a rationale combination of GOLF chemotherapy with cytokine-based immunotherapy could generate a chemotherapy-modulated Ag-specific T-lymphocyte response in cancer patients able to destroy the residual disease survived to the cytotoxic drugs.
- Subjects :
- Cytotoxicity, Immunologic
haplotype
peripheral blood mononuclear cell
Organoplatinum Compounds
Cytotoxic
HLA antigen class 1
Settore MED/06 - Oncologia Medica
Colorectal cancer
Cytotoxicity
T-Lymphocytes
medicine.medical_treatment
Drug Evaluation, Preclinical
Leucovorin
colon carcinoma
cytotoxic T lymphocyte
immunogenicity
immunomodulation
etoposide
Deoxycytidine
fluorouracil
carcinoembryonic Ag
Immunologic
Antineoplastic Combined Chemotherapy Protocols
Leukocytes
Cytotoxic T cell
Immunology and Allergy
irinotecan
Tumor
HLA A antigen
gemcitabine
apoptosis
article
Settore BIO/14
carcinoma cell
Preclinical
priority journal
Colonic Neoplasms
immunoblotting
HT29 Cells
dendritic cell
folinic acid
Mononuclear
Immunology
antineoplastic activity
thymidylate synthase
carcinoembryonic antigen
oxaliplatin
cancer immunotherapy
cell lysate
controlled study
cross presentation
flow cytometry
genetic transfection
human
human cell
Antigens, Neoplasm
Cell Line, Tumor
Coculture Techniques
Cross-Priming
Dendritic Cells
Fluorouracil
HLA-A Antigens
Humans
Leukocytes, Mononuclear
T-Lymphocytes, Cytotoxic
Cell Line
Antigen
HLA-A2 Antigen
medicine
GOLF
antitumor activity
Antigens
business.industry
CTL lines
Cancer
Dendritic cell
Immunotherapy
medicine.disease
digestive system diseases
CTL
Cancer cell
Cancer research
Neoplasm
Drug Evaluation
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Scopus-Elsevier, Università degli Studi di Siena-IRIS
- Accession number :
- edsair.doi.dedup.....d5657155c9e15f2b81234f42ab684de9